Artículo

Dual drug delivery systems based on natural and synthetic polymer particles for isoniazid and rifampicin vehiculization

Peverengo, Maria Rocio Icon; Ferrero, Francisco J. ; Turino, Ludmila Noelia Icon; Karp, Federico Icon; López, Marcela A. ; Luna, Julio Alberto Icon; Mengatto, Luciano Nicolas Icon

Otros responsables

Fecha

10/2024

Editorial

John Wiley & Sons

Revista

Journal of Applied Polymer Science

Título del libro

Nombre del evento

Fecha del evento

Institución organizadora

ISSN

0021-8995

eISSN

ISBN

Idioma

Inglés

Tipo del evento

Clasificación temática

Resumen

The purpose of this work is the design and characterization of novel systemsbased on micro and nanoparticles prepared from poly(lactic-co-glycolic) acid(PLGA), chitosan (CHT) and gelatin (GEL) for compartmentalization and dualrelease of rifampicin and isoniazid. The emulsion/evaporation method isemployed for the preparation of PLGA based microparticles and nanoparticles.CHT and GEL are used for the preparation of microparticles by spray-drying.Entrapment efficiencies are in the range of 35%–73% and 5%–29% for rifampicinand isoniazid in PLGA microparticles, respectively. For isoniazidGEL:CHT particles the entrapment efficiencies are within 82%–100%. Isoniazidshows a complete release at acid condition from GEL:CHT particles, whilerifampicin release is maintained from GEL:CHT particles or displays anslightly increase from PLGA particles during buffer conditions. Antimycobacterialactivity experiments show that the formulations present the ability toinhibit the bacterial growth in comparison with a control culture withouttreatment. Rifampicin PLGA and isoniazid GEL:CHT microparticles could beused for the preparation of a dual drug delivery system with each antibiotic ina single particulate compartment. GEL:CHT microparticles containing free isoniazidand rifampicin PLGA nanoparticles are a novel two compartment deliverysystem.

Aprobación

Revisión

Complementado por

Referenciado por

Licencia Creative Commons

Excepto donde se indique lo contrario, la licencia de este ítem se describe como by-nc-sa